Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP)

ABSTRACT: The primary objective of this study is to investigate the anti-angiogenic effect of bevacizumab measured by CTP as a predictive marker for efficacy measured by progression-free survival (PFS) in mCRC patients under first-line bevacizumab-containing, fluoropyrimidine-based chemotherapy

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2195199 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR